<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-874
Date of Submission: 2024-09-12

This report was submitted by a Pharmacist from Green-Wells Medical Center concerning patient ANON-PX-7501. The subject is a 46-year-old male with a significant medical history including coronary artery disease, seasonal allergies. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Amoxicillin (Penicillin antibiotic) administered via the Intravenous route at a dosage of 285mg, initiated on 2024-07-17 for Bacterial infection and discontinued on 2024-08-30; Gabapentin (Anticonvulsant) administered via the Subcutaneous route at a dosage of 396mg, initiated on 2024-07-17 for Neuropathic pain and discontinued on 2024-08-30.

On approximately 2024-07-18, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Anaphylaxis, Vomiting, Maculopapular Rash. The Anaphylaxis was classified as Severe in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Not Recovered'. The Vomiting was classified as Moderate in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Unknown'. The Maculopapular Rash was classified as Mild in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovering'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. A Naranjo score of 10 was calculated, The assessment concluded the relationship was 'Highly Probable'. Dechallenge/Rechallenge status was noted as: 'Not applicable'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Two seek glass section. Friend about do.</data>
report_id: ADR-2024-874
report_date: '2024-09-12'
patient_details:
  patient_id: ANON-PX-7501
  gender: Male
  relevant_history:
  - coronary artery disease
  - seasonal allergies
  age_at_reaction: 46
suspected_drugs:
- drug_name: Amoxicillin
  dosage: 285mg
  route_of_administration: Intravenous
  start_date: '2024-07-17'
  indication_for_use: Bacterial infection
  drug_class: Penicillin antibiotic
  end_date: '2024-08-30'
- drug_name: Gabapentin
  dosage: 396mg
  route_of_administration: Subcutaneous
  start_date: '2024-07-17'
  indication_for_use: Neuropathic pain
  drug_class: Anticonvulsant
  end_date: '2024-08-30'
adverse_reactions:
- symptom_name: Anaphylaxis
  onset_date: '2024-07-18'
  severity: Severe
  outcome: Not Recovered
  intervention_required: false
- symptom_name: Vomiting
  onset_date: '2024-07-18'
  severity: Moderate
  outcome: Unknown
  intervention_required: false
- symptom_name: Maculopapular Rash
  onset_date: '2024-07-18'
  severity: Mild
  outcome: Recovering
  intervention_required: false
causality_assessment:
  assessment_conclusion: Highly Probable
  dechallenge_rechallenge: Not applicable
  naranjo_score: 10
reporting_facility: Green-Wells Medical Center
reporter_type: Pharmacist
notes: Two seek glass section. Friend about do.
